Rubius Therapeutics Inc
(RUBY)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -32,581 | -89,195 | -62,012 | -35,650 | -14,411 |
| Depreciation Amortization | 661 | 1,263 | 879 | 502 | 227 |
| Accounts payable and accrued liabilities | -966 | 4,938 | 2,402 | 3,033 | 452 |
| Other Working Capital | 38 | 119 | 2,068 | 4,184 | 675 |
| Other Operating Activity | 9,976 | 24,534 | 18,015 | 7,144 | 2,168 |
| Operating Cash Flow | $-22,872 | $-58,341 | $-38,648 | $-20,787 | $-10,889 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | -117,983 | -175,924 | -87,369 | -78,425 | -56,148 |
| PPE Investments | -4,164 | N/A | -11,671 | -1,458 | -830 |
| Sale Of Investment | 29,155 | 64,285 | 33,460 | 13,710 | N/A |
| Investing Cash Flow | $-92,992 | $-111,639 | $-65,580 | $-66,173 | $-56,978 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | 246 | 245 | 245 | N/A |
| Debt Issued | N/A | 25,000 | N/A | N/A | N/A |
| Debt Repayment | N/A | -5,500 | N/A | N/A | N/A |
| Common Stock Issued | 799 | 64 | 18 | 18 | 4 |
| Other Financing Activity | 0 | 355,019 | 355,403 | 100,271 | 100,986 |
| Financing Cash Flow | $799 | $374,829 | $355,666 | $100,534 | $100,990 |
| Beginning Cash Position | 309,421 | 104,572 | 104,572 | 104,572 | 104,572 |
| End Cash Position | 194,356 | 309,421 | 356,010 | 118,146 | 137,695 |
| Net Cash Flow | $-115,065 | $204,849 | $251,438 | $13,574 | $33,123 |
| Free Cash Flow | |||||
| Operating Cash Flow | -22,872 | -58,341 | -38,648 | -20,787 | -10,889 |
| Capital Expenditure | -4,164 | N/A | -11,671 | -1,458 | -830 |
| Free Cash Flow | -27,036 | -58,341 | -50,319 | -22,245 | -11,719 |